Veritas In Silico is newly listed on TSE Growth Market.

Veritas In Silico has developed their ibVIS platform that combines informatics and experimental biology and has been conducting research for discovering mRNA-targeted small molecule drugs in collaboration with many pharmaceutical companies.

Global Brain is hopeful that Veritas In Silico will continue to make even greater strides as a pioneer paving the way for new areas in the pharmaceutical industry.

OUR TRACK RECORD

$1.9B

under management

350+

active portfolio

34

IPOs

70

M&As

We help startups get ready to take off on a global scale.

Global Brain is an independent venture capital firm that aims to bring new industries to the society through extensive hands-on support for startups and open innovation with large corporations.

Our Funds & Projects

A rare fund operation in the world that helps collaborations between startups and enterprise companies.

1,000+
deals
$1B+
invested
350+
active portfolio
$1.9B
under management

Our Team

Members with diverse backgrounds provide thorough support to our portfolio companies.

68

InvestmentMembers

29

SupportMembers

14

Fund ManagementMembers

29

OperationMembers

Contact Us

Inquiries from entrepreneurs are greatly appreciated. Please feel free to contact us even if you are in the process of preparing a project or if your idea has not yet taken shape.

The Global Brain mark is a registered trademark of Global Brain Corporation. Other marks and trade names are the property of their respective owners.